Black Rock Inc. Timber Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.24 - $0.39 $28,533 - $46,366	-118,889 Reduced 99.98%	19 $0
Q1 2022 May 12, 2022	BUY	$0.28 - $0.41 $10,671 - $15,626	38,114 Added 47.17%	118,908 $46,000
Q4 2021 Feb 10, 2022	BUY	$0.38 - $0.89 $786 - $1,842	2,070 Added 2.63%	80,794 $31,000
Q3 2021 Nov 09, 2021	SELL	$0.89 - $1.18 $13,433 - $17,810	-15,094 Reduced 16.09%	78,724 $71,000
Q2 2021 Aug 11, 2021	BUY	$1.06 - $2.25 $99,447 - $211,090	93,818 New	93,818 $114,000

Ticker TMBR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,524,992
Description
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.